-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMGS-001 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMGS-001 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMGS-001 in Metastatic Colorectal Cancer Drug Details: IMGS-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMGS-001 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMGS-001 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMGS-001 in Metastatic Ovarian Cancer Drug Details: IMGS-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMGS-001 in Metastatic Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMGS-001 in Metastatic Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMGS-001 in Metastatic Prostate Cancer Drug Details: IMGS-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMGS-001 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMGS-001 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMGS-001 in Triple-Negative Breast Cancer (TNBC) Drug Details: IMGS-001...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TmEGFR/IL13Ralpha2 01 CAR-T in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TmEGFR/IL13Ralpha2 01 CAR-T in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TmEGFR/IL13Ralpha2 01 CAR-T in Recurrent Glioblastoma Multiforme...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Yttrium 90-labelled edotreotide in Neuroblastoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Yttrium 90-Labelled Edotreotide in Neuroblastoma Drug Details:Onalta (edotreotide Labeled Yttrium 90) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cannabidiol in Fragile X Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cannabidiol in Fragile X Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol in Fragile X SyndromeDrug Details:Cannabidiol (ZYN-002) is under development for the...
-
Product Insights
Alibek South Field
Alibek South Field is a producing field located in Aktobe Oblast, Kazakhstan. It is being operated by Caspineft Tme. Empower your strategies with our Alibek South Field report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....